1. Regulatory considerations in biosimilars: Asia pacific regions.
- Author
-
Rathore, Anurag S. and Bhargava, Ankita
- Subjects
- *
BIOSIMILARS , *PER capita , *PATENTS , *SUPPLIERS , *INCOME - Abstract
Biosimilars are the biological drugs that are granted after the expiry of the patent of an affirmed innovator. Asia Pacific countries are characterized by significant demand as they account for majority of the world population and poor affordability due to low per capita income in most regions. Some of these countries offer potential to emerge as global suppliers of affordable, safe and efficacious biosimilars. This article highlights the prospects of biosimilars in the Asia Pacific market. Regulatory framework in the various countries is also discussed. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF